Dian Diagnostics Group Co.,Ltd. (300244.SZ)
CNY 13.99
(-1.34%)
CNY 13.99
(-1.34%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 998.13 Million CNY | -73.84% |
| 2022 | 3.81 Billion CNY | 107.57% |
| 2021 | 1.83 Billion CNY | -11.51% |
| 2020 | 2.07 Billion CNY | 74.18% |
| 2019 | 1.19 Billion CNY | 65.3% |
| 2018 | 721.39 Million CNY | 21.67% |
| 2017 | 592.9 Million CNY | 42.58% |
| 2016 | 415.85 Million CNY | 113.76% |
| 2015 | 194.54 Million CNY | 29.51% |
| 2014 | 150.21 Million CNY | 38.8% |
| 2013 | 108.22 Million CNY | 51.17% |
| 2012 | 71.59 Million CNY | 54.22% |
| 2011 | 46.42 Million CNY | 37.11% |
| 2010 | 33.85 Million CNY | 75.7% |
| 2009 | 19.27 Million CNY | 176.29% |
| 2008 | 6.97 Million CNY | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | 186.87 Million CNY | 22.4% |
| 2024 Q1 | 152.67 Million CNY | 205.93% |
| 2024 Q3 | 188 Million CNY | 0.6% |
| 2023 FY | 998.13 Million CNY | -73.84% |
| 2023 Q3 | 252.65 Million CNY | -39.73% |
| 2023 Q2 | 419.22 Million CNY | 16.29% |
| 2023 Q4 | -144.13 Million CNY | -157.05% |
| 2023 Q1 | 360.49 Million CNY | 162.69% |
| 2022 Q3 | 814.11 Million CNY | -45.78% |
| 2022 Q1 | 1.08 Billion CNY | 1702.56% |
| 2022 FY | 3.81 Billion CNY | 107.57% |
| 2022 Q4 | -575.01 Million CNY | -170.63% |
| 2022 Q2 | 1.5 Billion CNY | 38.75% |
| 2021 FY | 1.83 Billion CNY | -11.51% |
| 2021 Q1 | 485.78 Million CNY | 1001.32% |
| 2021 Q4 | 60.03 Million CNY | -91.93% |
| 2021 Q3 | 744.08 Million CNY | 35.77% |
| 2021 Q2 | 548.03 Million CNY | 12.81% |
| 2020 Q2 | 666.65 Million CNY | 2474.42% |
| 2020 Q4 | 44.1 Million CNY | -92.44% |
| 2020 FY | 2.07 Billion CNY | 74.18% |
| 2020 Q3 | 583.65 Million CNY | -12.45% |
| 2020 Q1 | 25.89 Million CNY | -78.15% |
| 2019 Q4 | 118.53 Million CNY | -38.81% |
| 2019 FY | 1.19 Billion CNY | 65.3% |
| 2019 Q1 | 150.45 Million CNY | -16.79% |
| 2019 Q2 | 311.84 Million CNY | 107.26% |
| 2019 Q3 | 193.72 Million CNY | -37.88% |
| 2018 Q2 | 244.42 Million CNY | 115.85% |
| 2018 Q1 | 113.23 Million CNY | -29.21% |
| 2018 Q3 | 182.91 Million CNY | -25.17% |
| 2018 Q4 | 180.81 Million CNY | -1.15% |
| 2018 FY | 721.39 Million CNY | 21.67% |
| 2017 Q1 | 103.93 Million CNY | -17.03% |
| 2017 Q3 | 143.63 Million CNY | -22.52% |
| 2017 Q4 | 159.95 Million CNY | 11.36% |
| 2017 FY | 592.9 Million CNY | 42.58% |
| 2017 Q2 | 185.37 Million CNY | 78.36% |
| 2016 FY | 415.85 Million CNY | 113.76% |
| 2016 Q4 | 125.26 Million CNY | 30.22% |
| 2016 Q3 | 96.19 Million CNY | -32.16% |
| 2016 Q2 | 141.8 Million CNY | 169.63% |
| 2016 Q1 | 52.59 Million CNY | 8.23% |
| 2015 Q3 | 47.36 Million CNY | -33.22% |
| 2015 Q4 | 48.59 Million CNY | 2.59% |
| 2015 Q1 | 27.65 Million CNY | -17.09% |
| 2015 FY | 194.54 Million CNY | 29.51% |
| 2015 Q2 | 70.92 Million CNY | 156.42% |
| 2014 Q3 | 35.68 Million CNY | -38.33% |
| 2014 FY | 150.21 Million CNY | 38.8% |
| 2014 Q1 | 23.3 Million CNY | -22.2% |
| 2014 Q2 | 57.86 Million CNY | 148.25% |
| 2014 Q4 | 33.36 Million CNY | -6.51% |
| 2013 Q4 | 29.96 Million CNY | 32.51% |
| 2013 FY | 108.22 Million CNY | 51.17% |
| 2013 Q1 | 16.23 Million CNY | -30.92% |
| 2013 Q2 | 39.42 Million CNY | 142.89% |
| 2013 Q3 | 22.6 Million CNY | -42.66% |
| 2012 Q2 | 23.26 Million CNY | 87.89% |
| 2012 Q4 | 23.5 Million CNY | 88.74% |
| 2012 Q3 | 12.45 Million CNY | -46.48% |
| 2012 Q1 | 12.38 Million CNY | -15.16% |
| 2012 FY | 71.59 Million CNY | 54.22% |
| 2011 Q4 | 14.59 Million CNY | 93.3% |
| 2011 FY | 46.42 Million CNY | 37.11% |
| 2011 Q2 | 14.75 Million CNY | 55.01% |
| 2011 Q1 | 9.52 Million CNY | 15.23% |
| 2011 Q3 | 7.54 Million CNY | -48.85% |
| 2010 Q1 | 8.03 Million CNY | 0.0% |
| 2010 Q4 | 8.26 Million CNY | 6.26% |
| 2010 Q3 | 7.77 Million CNY | -20.56% |
| 2010 Q2 | 9.78 Million CNY | 21.87% |
| 2010 FY | 33.85 Million CNY | 75.7% |
| 2009 FY | 19.27 Million CNY | 176.29% |
| 2008 FY | 6.97 Million CNY | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Hangzhou Tigermed Consulting Co., Ltd. | 2.48 Billion CNY | 59.865% |
| Dirui Industrial Co.,Ltd. | 296.87 Million CNY | -236.214% |
| Beijing Strong Biotechnologies, Inc. | 593.87 Million CNY | -68.071% |
| Medicalsystem Biotechnology Co., Ltd. | 279.11 Million CNY | -257.604% |
| Maccura Biotechnology Co.Ltd | 331.14 Million CNY | -201.419% |
| Guangzhou Wondfo Biotech Co.,Ltd | 549.13 Million CNY | -81.763% |
| Guangdong Hybribio Biotech Co.,Ltd. | 42.59 Million CNY | -2243.048% |
| BGI Genomics Co., Ltd. | 150.64 Million CNY | -562.554% |
| Amoy Diagnostics Co., Ltd. | 301.24 Million CNY | -231.334% |
| Shanghai Labway Clinical Laboratory Co., Ltd. | -135.82 Million CNY | 834.873% |